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Control of mosquito-borne pathogens using genetically-modified vectors has been
proposed as a promising tool to complement conventional control strategies.
CRISPR-based homing gene drive systems have made transgenic technologies
more accessible within the scientific community. Evaluation of transgenic mosquito
performance and comparisons with wild-type counterparts in small laboratory cage
trials provide valuable data for the design of subsequent field cage experiments and
experimental assessments to refine the strategies for disease prevention. Here, we
present three different protocols used in laboratory settings to evaluate transgene
spread in anopheline mosquito vectors of malaria. These include inundative releases
(no gene-drive system), and gene-drive overlapping and non-overlapping generation
trials. The three trials vary in a number of parameters and can be adapted to desired
experimental settings. Moreover, insectary studies in small cages are part of the
progressive transition of engineered insects from the laboratory to open field releases.
Therefore, the protocols described here represent invaluable tools to provide empirical
values that will ultimately aid field implementation of new technologies for malaria
elimination.
Introduction
Strategies based on genetically-engineered mosquitoes are
being pursued to control transmission of vector borne
pathogens such as those that cause malaria. These include
technologies 1) aimed at decreasing the numbers and
densities of Anopheles mosquitoes (population suppression),
or 2) aimed at impairing the ability of vectors to
transmit parasites responsible for human disease (population
modification, replacement, or alteration) wherein strains of
vectors are engineered to express effector genes that
prevent pathogen transmission. These genetic approaches
have been bolstered by the advent of CRISPR/Cas9-based
gene drives, with proofs-of-concept in parasite-transmitting
Copyright © 2021  JoVE Journal of Visualized Experiments jove.com April 2021 •  •  e62588 • Page 2 of 14
mosquitoes of effective spread of payload traits as well as
anti-parasitic effector molecules in caged populations.
Small laboratory cage trials represent a first step for
evaluating the characteristic of transgenic strains as
part of a phased approach to their further development
towards field applications2 . Specific outcome considerations
include heritability of the introduced DNA in a competitive
environment, penetrance and expressivity of the phenotype,
and stability. Relevant experimental design features include
the size of the cages, mosquito densities, number of
replicates, overlapping or non-overlapping generations, age-
structured target populations, single or multiple releases
of engineered strains, male-only, female-only or mixed-sex
releases, release ratios, blood meal sources (artificial or live
animal), and screening procedures.
We describe here protocols used to evaluate strains of
anopheline mosquitoes for inundative releases (no gene-
drive system) and those that carry autonomous gene-drive
systems mediated by Cas9 endonucleases and guide RNAs
(gRNA). Applications of these protocols appear in Pham et
al. (2019)2 , Carballar-Lejarazú et al. (2020)3 , and Adolfi et al.
(2020)4 .
Inundative release trials evaluate the spreading rate of a
designed transgene under Mendelian inheritance following
multiple releases of a large number of transgenic mosquitoes
into a wild population. Without the attachment of the
transgene to a drive system, data from inundative release trial
provides information regarding the fitness and dynamic of the
transgene of interest in a stabilized population.
When mosquito populations contain an autonomous gene-
drive system, small cage trials are designed to assess
the dynamics of the spread of the desired transgene by
determining the rate of dominant marker increase following
a single introduction of transgenic males. Autonomous gene-
drive elements carry the genes encoding the Cas9 nuclease,
gRNA and dominant marker linked in such a fashion as to be
active in subsequent generations.
'Overlapping' generations refer to the simultaneous presence
of multiple generations in the same cage to create an
age-structured continuous population, while 'non-overlapping'
refers to single discrete generations in each consecutive
caged population2 . Gene-drive cage experiments can be
terminated once the initial dynamics of the drive (conversion)
rate can be determined (8-10 generations depending on the
construct), and while they provide information on the short-
term stability of the transgene within the mosquito population,
they may not reveal what happens when and if the dominant
marker frequencies reach or are close to full introduction
(every mosquito carrying at least one copy of the gene-drive
system).
Protocol
1. Inundative release trials on non-gene drive
mosquitoes (Figure 1)
1. Cage setup and maintenance
1. Set up three sets of triplicate 0.216 m3  cages by
adding 60 second-instar wild-type (WT) larvae in
each cage over three successive weeks.
 
NOTE: It is not possible to determine the sex of
second-instar larvae, so the samples added to each
cage will consist of both males and females.
2. At every week, provide adult females in each cage
with anesthetized mice as bloodmeal source (Figure
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2A) and an oviposition container 3 days after the
bloodmeal.
 
NOTE: While an alternative artificial feeding
apparatus can be used, providing live anesthetized
mice for bloodmeals results in better mosquito
feeding performance in these large (0.216 m3 ) cage
formats. This requires an approved animal use
protocol and relevant (e.g., Institutional Animal Care
and Use Committee, IACUC) approval for using
mice.
3. Hatch eggs from each cage weekly and select 60
second-instar (L2) larvae at random to be returned
to their respective cages to offset mortality (weeks
4-8).
 
NOTE: Steps 1.1.1 to 1.1.3 are necessary to
establish a stable and distributed age-structured
population in the cages - referred to as 'Initial Phase'.
4. At week 9, assign cages assembled in step 1.1.1
randomly in triplicates for releases of the desired
male release ratio.
1. Designate one set of triplicate cages as
controls to assess consistency throughout the
experiment.
2. Designate one set of triplicates for each
desired release ratio (for example, 1:1 or 1:0.1
transgenic:WT males)..
 
NOTE: This point on is referred to as
'Experimental Phase'.
2. Replicates and release ratios
1. Add 60 WT pupae (30 males and 30 females) to the
control cages weekly.
2. To maintain a 1:1 ratio, add weekly 30 transgenic
male pupae along with 60 (30 male and 30 female)
WT pupae into each respective cage.
3. To maintain a 1:0.1 ratio, add weekly 300 transgenic
male pupae along with 60 (30 male and 30 female)
WT pupae into each respective cage.
 
NOTE: Continued addition of wild mosquitoes to the
cages maintains the cage density, which is expected
to diminish weekly due to age-related adult mortality.
3. Screening of phenotypes
1. Select a total of 300 larvae from each cage at
random. With the use of a stereo microscope
equipped with fluorescence filters, screen for the
expression of the fluorescent dominant marker at the
larval and pupal stages and score the sex of the
resulting adults (Figure 3).
 
NOTE: The phenotypical screening will depend on
the dominant marker included in the transgene
construct integrated into the mosquitoes (for
example, Discosoma sp. red fluorescent protein
[DsRed], cyan fluorescent protein [CFP], green
fluorescent protein [GFP]), and on the promoter
driving its expression (the most used in mosquito
transgenesis is the 3xP3 promoter driving
expression in the eyes and nerve cord).
2. Follow this protocol for as many generations as
required by the outcome parameters defined in the
experimental design.
 
NOTE: The trial is usually terminated when all
mosquitoes have at least one copy of the transgene
(determined by the presence of the dominant
fluorescent marker) or the ratio of transgenic-to-WT
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mosquitoes in a cage is stabilized and does not
fluctuate greatly after a few (3-5) generations.
2. Overlapping generation trials of gene-drive
mosquitoes (Figure 4)
NOTE: Mosquitoes carrying gene-drive systems require
written and reviewed protocols and should be approved by
an Institutional Biosafety Committee (IBC) or equivalent, and
others where required. Mosquito containment (ACL 2+  level)
should follow recommended procedures5,6 ,7 . Specifically,
the gene drive experiments should employ two stringent
confinement strategies. The first is usually physical barriers
(Barrier Strategy) between organisms and the environment.
This requires having a secure insectary and standard
operating procedures (including monitoring) for ensuring that
mosquitoes cannot escape. The second confinement strategy
can be Molecular, Ecological or Reproductive5 .
1. Cage setup
1. Set up two sets of triplicate 0.216 m3  cages for each
desired transgenic:WT male release ratio.
1. To achieve a male release ratio of 1:1, add
120 transgenic males, 120 WT males and 120
WT females at the pupa stage to each replicate
cage.
2. To achieve a release ratio of 1:10, add 12
transgenic males, 120 WT males and 120 WT
females at the pupa stage to each replicate
cage.
 
NOTE: Different release ratios can be tested
(1:1, 1:3, 1:10, etc.) and the number of
mosquitoes used to initiate the experiments
varies accordingly. However, it is important to
consider the effects of low numbers on the
statistical evaluation of the data.
2. Population maintenance and screening
1. Provide 4-7 days old females in each cage with a
blood meal using anesthetized mice (Figure 2A).
2. Three days after the blood meal, insert an oviposition
container in each cage.
3. Hatch eggs in a larval tray, select ~240 first instar
(L1) larvae at random from each cage, rear them to
adulthood, and return them to their respective cages.
4. Provide additional (2-3) blood meals every 3-4 days
for the newly emerged adults as described in step
2.2.1.
 
NOTE: No additional transgenic males are added
during any of the subsequent generations.
5. Select a total of 300 larvae from each cage at
random and screen them for the presence of the
dominant marker phenotype at the larval and pupal
stages using a fluorescence stereo microscope and
score emerging adults for sex (Figure 3).
 
NOTE: As before, the phenotypical screening will
depend on the dominant marker and promoter
included in the gene-drive system and integrated
into the transgenic mosquitoes (DsRed, CFP or
GFP). If homozygous or heteroallelic disruptions of
the targeted genes result in a visible phenotype
(for example, genes related to eye pigmentation),
screening of this trait will depend on which stage it
is easiest to visualize the altered phenotype.
6. Follow this protocol for as many generations as
required by the outcome parameters defined in the
experimental design.
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NOTE: Each generation (delimited by the blood
meal) takes ~three weeks. The trial is usually
terminated when all mosquitoes are deemed
homozygous for the gene-drive construct or the
populations stabilize at a maximum percentage of
mosquitoes carrying at least one copy of the gene-
drive construct.
3. Non-overlapping generation trials of gene-drive
mosquitoes (Figure 5).
1. Cage setup
1. Set up triplicate 0.005 m3  cage populations for each
specific release ratio of transgenics to WT males to
be investigated (for example, three sets of triplicate
cages each set up with 1:1, 1:3, 1:10 release ratios).
Set up all cages with an equal total number of males
and females.
 
NOTE: The Supplementary File is a video
demonstrating the construction of the 0.005 m3
colony cage.
1. Add 50 transgenic males, 50 WT males, and
100 WT females to each of three replicate cages
to achieve a 1:1 male release ratio.
2. Add 25 transgenic males, 75 WT males, and
100 WT females to each of three replicate cages
to achieve a 1:3 male release ratio.
3. Add 10 transgenic males, 90 WT males, and
100 WT females to each of three replicate cages
to achieve a 1:10 male release ratio.
 
NOTE: Different release ratios can be tested
and the number of mosquitoes used to
initiate the experiments can vary accordingly.
However, it is important to consider the
impact of low numbers of mosquitoes on the
statistical analyses. These are single releases;
no additional transgenic males are added at any
subsequent generation.
2. Population maintenance and screening
1. Provide the 4-7 days old females in each cage with
blood meals using an artificial feeding apparatus
(Figure 2B) on two consecutive days.
 
NOTE: Routine blood meals for females consist
of a commercially available source of blood (e.g.,
calf's blood) provided from a feeding apparatus.
Live anesthetized mice are used only to provide
bloodmeals in larger (0.216 m3 ) cage formats for
better feeding performance.
2. Add an oviposition container 3 days after the second
bloodmeal. After three days, remove the oviposition
containers.
 
NOTE: At this step, 5-10 females can be selected
at random from each cage and placed individually in
vials to assess additional fitness parameters, such
as fertility and fecundity, if needed.
3. Score by sex all adults (dead and alive) remaining
in the cage and store them at -80°C for molecular
analysis.
4. Hatch eggs and randomly select 200 L1 larvae from
the 1:1 and 1:3 ratio cages to populate new cages
for the next generation.
 
NOTE: Due to the low frequency of starting
transgenic individual in the 1:10 ratio cages, random
sampling may lead to excessive loss of transgenic
progeny in the next generation to carry on the
population.
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5. To ensure an accurate sampling for the 1:10 cages
and sufficient numbers of transgenic mosquitoes,
screen all larvae for the dominant marker and
select 200 larvae reflecting the observed transgene
frequency to populate the new cages.
 
NOTE: The 1:10 cages can be maintained identically
to 1:1 and 1:3 cages when they reach a transgene
frequency of ≥80%.
6. Select 500 larvae from each cage at random for
an in-depth analysis. Screen under a fluorescence
stereo microscope for the expected marker
phenotypes at the larval and pupal stages and score
sex on adults (Figure 3).
 
NOTE: 'Exceptional' phenotypes can be selected
to be further crossed and analyzed molecularly to
monitor resistant allele formation.
7. This protocol can be followed for as many
generations as required by the outcome parameters
defined in the experimental design.
 
NOTE: Each generation is delimited by the
bloodmeal and takes ~three weeks. The trial
is usually terminated when all mosquitoes are
deemed homozygous for the gene-drive construct
or populations stabilize at a maximum prevalence
of transgenic mosquitoes. And as before, screening
for phenotypes will depend on the dominant
markers and promoter integrated in the transgenic
mosquitoes (for example, DsRed, CFP, GFP) or
in the targeted genes if they present a visible
phenotype (for example, genes related to eye
pigmentation).
Representative Results
Transgenic anopheline mosquitoes generated to bear non-
gene drive or autonomous gene-drive modifications are set
up for cage trials as described in the Protocols section.
The representative results shown here depict the phenotype
dynamics of the best-performing replicates of each of the
cage trials experiments performed by Pham et al. (2019)2
for Anopheles stephensi mosquitoes. The three trials (1 - 3,
respectively: inundative non-gene drive, overlapping gene-
drive and non-overlapping gene-drive) varied in different
parameters, such as the size of the cage (0.216 m3  vs 0.005
m3 ), whether or not the target population was age-structured,
source of blood meal (mice or artificial feeder) and release
ratios. As a means of representation, Figure 6 displays the
observed data selected from the same release ratio (1:1) for
all three protocols used, on the course of seven generations.
The 1:1 non-drive release reaches >80% transgene
introduction within 6-7 generations. For gene-drive transgenic
cage trials, the 1:1 releases in both the non-overlapping and
overlapping protocols reach this level within 3-4 generations,
thus, validating the expectation that a single release of a gene
drive system can be more efficient than non-drive inundative
releases for transgene introduction. The faster trajectory can
also be confirmed by the slope of the trendlines. Both gene-
drive protocols, despite different set ups, present similar
angles and slope trends. At the end of observation, non-drive
cages achieve ~80% of individuals bearing the transgene,
while cages with gene-drive individuals reach complete (or
near complete) introduction. Complete data and processing
details on individual experiment results using the protocols
described here can be found in Figures 1-3 of Pham et al.
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(2019)2 , Figures 2-3 of Carballar-Lejarazú et al. (2020)3  and
Figure 3 of Adolfi et al. (2020)4 .
 
Figure 1. Non-drive inundative release trial schematic.  Nine 0.216 m3  cages are set up with 60 wild-type second-instar
(mixed-sexes) larvae added to each. Beginning week 3, females are provided a bloodmeal weekly and eggs are collected
and hatched. Until week 8, 60 larvae are randomly selected and returned to their respective cages weekly to create an
age-structured population in the cages (initial phase). Beginning week 9, the nine cages are randomly assigned in triplicate
according to their transgenic:wild-type male release ratios (experimental phase). Cages A (Control) have no transgenic
pupae added. Females are provided a bloodmeal weekly and eggs are collected, hatched, and reared to pupae. 30 male
and 30 female wild- type pupae are added back to their cages. Cages 1:1 have an additional 30 transgenic male pupae
added. Cages 1:0.1 have an additional 300 transgenic male pupae added. 300 larvae from each of the 9 cages are selected
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randomly and screened for the fluorescent marker. This procedure was repeatedly weekly until transgene fixation (stabilized
ratio of transgenic-wildtype mosquitoes after a few generations). Adapted from Pham et al. (2019)2 . Please click here to view
a larger version of this figure.
 
Figure 2. Blood feeding of cage populations.  (A) Anesthetized mice or (B) Hemotek blood feeders are offered for blood
feeding female mosquitoes on the 0.216 m3  cages or the small 0.005 m3  cages, respectively. Please click here to view a
larger version of this figure.
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Figure 3. Screening phenotypes for non-drive, overlapping gene-drive and non-overlapping gene-drive cage trials.
  Fluorescent images of a larva, pupa and adult of transgenic or wild-type phenotypes. In this example, An. stephensi
individuals were screened for the DsRed marker driven by the 3xP3 promoter in the eyes (DsRed+ or DsRed-), visible in all
three stages, and adults were screened for sex (♀ or♂). Note the background fluorescence in wild-type larvae associated
with the food bolus in the midgut. Please click here to view a larger version of this figure.
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Figure 4. Overlapping gene-drive cage trial schematic.  Six 0.216 m3  cages are set up in triplicate according to their
gene-drive:wild-type male release ratios. 120 wild-type males and 120 wild-type females were added to each cage. Cages
with a 1:1 gene-drive male release ratio had an additional 120 transgenic males added. Cages with a 1:10 male release
ratio had an additional 12 transgenic males added. Until full introduction of the transgene, every 3 weeks, adult females are
provided bloodmeals and eggs are collected and hatched. A total of 240 larvae were selected randomly and returned to
their respective cages. Three-hundred (300) larvae are selected randomly and screened for the dominant marker. They are
later screened as pupae and adults for eye-color and sex. No additional transgenic males are added to the original cages.
Adapted from Pham et al. (2019)2 . Please click here to view a larger version of this figure.
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Figure 5. Non-overlapping gene-drive cage trial schematic.  Nine small 0.005 m3  cages are set up in triplicate according
to their gene-drive:wild-type male release ratios. Cages with a 1:1 male release ratio have 100 wild-type females, 50 wild-
type males, and 50 gene-drive males added. Cages with a 1:3 male release ratio have 100 wild-type females, 75 wild-type
males, and 25 gene-drive males added. Cages 1:10 male release ratio have 100 wild-type females, 90 wild-type males, and
9 gene-drive males added. Females are provided a blood meal and eggs collected and hatched. For 1:1 and 1:3 cages, 200
larvae are selected randomly and used to populate new cages, separate from that of their parents, for the next generation.
An additional 500 larvae are selected randomly and reared to pupae, when they are screened for the dominant marker gene.
The 500 pupae are then reared to adults and scored by sex. All remaining larvae are screened for the marker. For the 1:10
cages, all larvae are scored in generations 1-12 and 200 larvae reflecting the existing transgene frequency are used to
populate new cages. Beginning at generation 13, these cages are set up identically to the 1:1 and 1:3 cages. Adapted from
Pham et al. (2019)2  and Carballar-Lejarazú et al. (2020)3 . Please click here to view a larger version of this figure.
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Figure 6. Predicted transgene fixation dynamics for the different population replacement cage trials.  Representation
of the expected phenotype dynamics of the best-performing replicates for each of the cage trials experiments performed by
Pham et al. (2019)2 , monitored over 7 generations. Experiments set ups are described in the Protocols. The predictions are
based on data from all 9 experiments on the 1:1 release models (triplicate replicates for each of the three different cage trial
protocols). The X-axis is the generation number after initial introduction and the Y-axis is the proportion of larvae showing the
DsRed marker phenotype (DsRed+) over time. Dashed lines represent linear trendlines of the data. The DsRed+ phenotype
results from having at least one copy of the modified allele. Hence the results reflect the spread of the transgene, expedited
in the gene drive system, reaching (near) full introduction at the end of the observation. For the variability between replicates
and full detailed data on the experiments, please refer to Pham et al. (2019)2 , Carballar-Lejarazú R et al. (2020)3  and Adolfi
A et al. (2020)4 . Images adapted from Pham TB et al. (2019) Experimental population modification of the malaria vector
mosquito, Anopheles stephensi. PLOS Genet 15(12): e1008440. doi: 10.1371/journal.pgen.1008440, Adolfi A et al. (2020)
Efficient population modification gene-drive rescue system in the malaria mosquito Anopheles stephensi. Nat Commun 11(1):
5553. doi: 10.1038/s41467-020-19426-0 and Carballar-Lejarazú R et al. (2020) Next-generation gene drive for population
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modification of the malaria vector mosquito, Anopheles gambiae. Proc Natl Acad Sci USA 117(37):22805-22814. doi:
10.1073/pnas.2010214117. Please click here to view a larger version of this figure.
Supplemental File: The construction of the 0.005 m3
colony cage. Please click here to download this File.
Discussion
Genetically-engineered mosquitoes that have pathogen
blocking ability or bear sterility genes constitute new tools
to control vector-borne diseases. Given the multiplicity of
parameters that comprise these alternative approaches, a
critical step in their research consists of laboratory-confined
experimental evaluations that allow a fast and safe prediction
of the potential outcomes of a synthetic transgene release for
control purposes1 .
Because the monitoring of the transgene dynamics in
caged populations can extend for several months, one of
the central aspects of the protocols is the consistency in
experimental design between replicates (including mosquito
rearing, cage size, age-structured populations, fixed release
ratios, stable blood meal sources and minimally invasive
screening procedures).
Male-only releases are considered ideal because male
mosquitoes neither transmit pathogens nor feed on humans,
therefore they can safely introduce heritable characteristics
into wild populations. In laboratory cage experiments, it
is possible to detect transgenic strains with reduced male
mating competitiveness and other fitness loads associated
with transgene integration. However, direct and specific
experiments, such as those conducted in large cages10 ,
can be conducted to properly analyze male competitiveness,
as well as female fecundity in more natural mosquito
densities2 . Furthermore, empirical data from the cage trials
can be used to parameterize models of cage population
dynamics, including resistant allele formation, and provide
useful information on effectiveness and possible adjustments
in the proposed technology.
The protocols described here can be easily adapted to other
experimental designs as required, with minimal requirements
regarding regular insectary infrastructure and conditions. In
addition, except for the commercial cages and microscopes,
most of the materials are inexpensive and allow low-cost
multiple replicates and iterations of the trials. Notably, this
also allows multiple transgenic strains to be pre-screened
in small cage trials in order to prioritize best-performing
candidates to be moved forward in the phased testing
pathway and to suspend testing on those showing sub-
optimal performances.
Finally, concern regarding the use of genetically modified
organisms motivates the elaboration of frameworks for
the development, evaluation, and application of genetic
strategies for prevention of mosquito-borne diseases5,8 ,9 .
The relevance and execution of the protocols defined here
are consistent with these guidelines.
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